Polymorphous low-grade neuroepithelial tumor of the young
Showing 1 - 25 of >10,000
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,
Not yet recruiting
- Anaplastic Astrocytoma
- +17 more
- (no location specified)
Jun 28, 2023
Recurrent World Health Organization (WHO) Grade II Glioma Trial in United States (Everolimus, Trametinib)
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
-
Birmingham, Alabama
- +11 more
May 6, 2022
Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)
Recruiting
- Low-Grade Glioma
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 24, 2022
Low-grade Glioma, Advanced Solid Tumor Trial in Worldwide (DAY101)
Recruiting
- Low-grade Glioma
- Advanced Solid Tumor
-
San Francisco, California
- +35 more
May 25, 2022
MVNT (Multinodular and Vacuolating Neuronal Tumor)
Recruiting
- Benign Neuronal Desease
- cerebral MRI
-
Bordeaux, France
- +6 more
Mar 18, 2022
Rare Embryonal Tumors of Central Nervous System: International
Not yet recruiting
- Embryonal Tumor
-
Yerevan, ArmeniaHematology Center named after prof. R. Yeolyan
Jan 25, 2023
NF1, Low-grade Glioma Trial in United States (Poly ICLC)
Recruiting
- NF1
- Low-grade Glioma
- Poly ICLC
-
Birmingham, Alabama
- +18 more
Jan 5, 2023
Brain Tumors Trial in San Diego, Atlanta (Poly ICLC)
Completed
- Brain Tumors
- Poly ICLC
-
San Diego, California
- +1 more
Apr 20, 2022
Grade 1 Glioma, Mixed Glio-neuronal Tumors, Pleomorphic Xanthoastrocytoma Trial in Strasbourg (Trametinib, Vinblastine)
Recruiting
- Grade 1 Glioma
- +2 more
-
Strasbourg, FranceCHU Strasbourg - France
Jul 7, 2022
Stored Tumor Samples in Young Patients With Brain Tumors
Recruiting
- Brain and Central Nervous System Tumors
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 5, 2022
Frameshift Peptides of Children With NF1
Completed
- Neurofibromatosis Type 1
- Frameshift Array blood sample test
-
Washington, District of Columbia
- +2 more
Aug 29, 2022
Glioma, High Grade Glioma, Glioma, Malignant Trial in Philadelphia (18F-Fluciclovine PET-MRI)
Recruiting
- Glioma
- +4 more
- 18F-Fluciclovine PET-MRI
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Dec 22, 2022
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
The Immune Landscape of Epithelial Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- Collection of tumor samples, blood and vaginal and rectal swabs
-
Bellinzona, SwitzerlandOncology Institute of Southern Switzerland
Aug 2, 2023
Glioma, Low-grade Glioma, Low Grade Glioma of Brain Trial in Philadelphia (18F-Fluciclovine)
Not yet recruiting
- Glioma
- +4 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Oct 3, 2022
Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States
Recruiting
- Recurrent Low Grade Astrocytoma
- +4 more
- Quality-of-Life Assessment
- +3 more
-
Birmingham, Alabama
- +64 more
Aug 20, 2022
5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for
Not yet recruiting
- High Grade Glioma
- +10 more
- 5-Aminolevulinic Acid (5-ALA) Gliolan®
- Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
-
Guayaquil, Guayas, EcuadorSociedad de Lucha Contra el Cáncer
Apr 28, 2023
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade
Recruiting
- Low Grade Glioma (LGG) of Brain With BRAF Aberration
- +2 more
- Dabrafenib
- +2 more
-
Phoenix, Arizona
- +12 more
Apr 7, 2022
Low-grade Oral Dysplasia Trial in Boston (Probiotic oral lozenges, Standard of care for oral dysplasia)
Not yet recruiting
- Low-grade Oral Dysplasia
- Probiotic oral lozenges
- Standard of care for oral dysplasia
-
Boston, MassachusettsBoston Medical Center
Jan 22, 2023
Brain Cancer Trial in Canada, United States (cetuximab in conjunction with external beam radiation therapy, followed by
Completed
- Brain Cancer
- cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
-
Phoenix, Arizona
- +11 more
Mar 2, 2022
Low Grade Glioma Trial in Heidelberg (model-guided optimization of treatment plan, standard treatment plan, no optimization)
Not yet recruiting
- Low Grade Glioma
- model-guided optimization of treatment plan
- standard treatment plan, no optimization
-
Heidelberg, GermanyDepartment of Radiotherapy, University of Heidelberg
Jul 19, 2023
CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)
Active, not recruiting
- Central Nervous System Neoplasms
- Medulloblastoma
-
Stanford, California
- +24 more
Sep 28, 2022
Low Rectal Cancer Trial in Hanzhou (Modified short-course radiotherapy, PD-1 antibody, Capecitabine)
Not yet recruiting
- Low Rectal Cancer
- Modified short-course radiotherapy
- +3 more
-
Hanzhou, Zhejiang, ChinaSir Run Run Shao hospital
Jul 31, 2023